HW Kelly - The Annals of pharmacotherapy, 2005 - Harvey Whitney Books STUDY SELECTION AND DATA EXTRACTION: Randomized clinical trials, retrospective
and prospective cohort studies, and meta-analyses published in the past 3 years
were reviewed. Studies assessing the potential for ß 2 -agonists to worsen ... Cited by 10 - Related articles - All 4 versions
JAE Walters, R Wood-Baker, EH Walters - Respiratory medicine, 2005 - Elsevier According to major asthma management guidelines, long-acting β 2 -agonists
(LABAs) should be used only when asthma remains symptomatic in patients already
receiving regular inhaled corticosteroids (ICSs). A large Cochrane ... Cited by 23 - Related articles - All 10 versions
HW Kelly - Pediatric Asthma, Allergy & Immunology, 2006 - liebertonline.com H . W ILLIAM K ELLY , P HARM . D., is a Professor Emeritus of Pe- diatrics and
Pharmacy at the Department of Pediatrics, School of Medicine, University of New
Mexico Health Sciences Cen- ter. After completing his Bachelor of Pharmacy ... Cited by 5 - Related articles - BL Direct
- ►nih.gov [PDF] HW Kelly, MS Harkins, H Boushey - Journal of the National Medical Association, 2006 - pubmedcentral.nih.gov The role of inhaled beta-2 agonists in the management of asthma has changed
significantly over the last several years. This review outlines the most recent
understanding of the pathophysiology of asthma and the studies that define ... Cited by 5 - Related articles - BL Direct - All 3 versions
[CITATION] Consensus conference on aerosols and delivery devices
A Vatrella, R Parrella, G Pelaia, GL Biscione, … - European journal of clinical pharmacology, 2001 - Springer Abstract Objectives: The aim of this study was to eval- uate the e ects of
non-bronchoconstrictive doses of propranolol on airway hyperresponsiveness to
meth- acholine. Methods: Double increasing concentrations (from 0.03 to 64 ... Cited by 8 - Related articles - BL Direct - All 3 versions
PY Qaqundah, RW Sugerman, E Ceruti, JF … - The Journal of pediatrics, 2006 - Elsevier The FP-treated children had significantly greater (P ≤ .05) reductions in
24-hour daily asthma symptom scores (−53.9% vs −44.1%) and nighttime symptom
scores over the entire treatment period compared with the placebo group. ... Cited by 10 - Related articles - All 16 versions
H William - PEDIATRIC ASTHMA, ALLERGY & IMMUNOLOGY, 2006 - liebertonline.com H . W ILLIAM K ELLY , P HARM . D., is a Professor Emeritus of Pe- diatrics and
Pharmacy at the Department of Pediatrics, School of Medicine, University of New
Mexico Health Sciences Cen- ter. After completing his Bachelor of Pharmacy ... Related articles - All 2 versions
M Boterman, 2006 - dissertations.ub.rug.nl The research project described in this thesis was performed within the framework
of the Groningen Graduate School of Behavioral and Cognitive Neuroscience (BCN),
and the Groningen Research Institute for Asthma and COPD (GRIAC), and was ... Related articles - View as HTML - All 2 versions
HW Kelly - Expert Opin. Pharmacother., 2007 - informahealthcare.com The non-corticosteroids approved for the maintenance therapy of persistent
asthma include the long-acting inhaled β 2 agonists (LABAs), leukotriene
modifiers, chromones, theophylline and omalizumab. This review assesses the ... Related articles - BL Direct - All 6 versions
